This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David L. Kendler, MD, FRCPC; Jodie Lippa, MD; Jack Rootman, MD, FRCSC

Arch Ophthalmol. 1993;111(2):197-201.

Abstract
• A better understanding of the clinical nature of Graves' orbitopathy will aid in the treatment of the disease as well as help to form a basis for clinical and pathophysiologic investigations. We studied the clinical data of 557 consecutive patients who were referred for treatment of Graves' orbitopathy. Clinical indexes were calculated based on ophthalmologic variables measured, grouped in the following categories: soft tissue, proptosis, muscle limitation, increase in intraocular pressure on upgaze, corneal staining, and visual acuity. The mean age at onset of orbital disease was 43.9 years for men and 44.4 years for women, an average of 2.5 years from the onset of thyroid disease. The male-female ratio was 0.29 in all age groups. Women were more likely to present with orbitopathy and hypothyroidism than were men (20% vs 11%) and less likely to be euthyroid (16% vs 34%, P<.01). Patients older than 50 years, compared with their younger counterparts, more often had symptoms of impaired ocular motility (32% vs 12%), signs of softtissue involvement (77.5% vs 68.6%), asymmetric soft-tissue involvement (15.6% vs 7.8%), more limited upward duction (22.2° vs 29.4°), and more impaired Log-MAR visual acuity (0.092 vs 0.047, P<.01). Men had more limited upward duction than women (24.6° vs 27.1°) and greater increases in intraocular pressure on upgaze (7.80 mm Hg vs 5.78 mm Hg, P<.001). These data show thyroid orbitopathy to be a disease most common in younger women, but more severe, by most indexes, in men and patients older than 50 years. These groups of patients are also more likely to have asymmetric or euthyroid disease.

Author Affiliations
From the Departments of Ophthalmology (Drs Kendler and Rootman) and Medicine (Drs Kendler and Lippa), The University of British Columbia, Vancouver.

Footnotes
Accepted for publication August 11, 1992.

Reprint requests to Thyroid Orbitopathy Clinic, The University of British Columbia, Department of Ophthalmology, Eye Care Center, 2550 Willow St, Vancouver, BC, Canada V5Z 1N9 (Dr Kendler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of CTLA-4 and IL-13 Gene Polymorphisms with Graves' Disease and Ophthalmopathy in Chinese Children
Chong et al.
IOVS 2008;49:2409-2415.
ABSTRACT | FULL TEXT  

Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype
Manji et al.
J. Clin. Endocrinol. Metab. 2006;91:4873-4880.
ABSTRACT | FULL TEXT  

Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy
Boschi et al.
Br J Ophthalmol 2005;89:724-729.
ABSTRACT | FULL TEXT  

Unilateral proptosis: the role of medical history
Kamminga et al.
Br J Ophthalmol 2003;87:370-371.
FULL TEXT  

Insights Into the Pathogenesis of Thyroid-Associated Orbitopathy: Evolving Rationale for Therapy
Kazim et al.
Arch Ophthalmol 2002;120:380-386.
FULL TEXT  

Management of Graves' Ophthalmopathy: Reality and Perspectives
Bartalena et al.
Endocr. Rev. 2000;21:168-199.
ABSTRACT | FULL TEXT  

Radiotherapy for Thyroid Orbitopathy: Effects on Extraocular Muscle Balance
Wilson and Prochoda
Arch Ophthalmol 1995;113:1420-1425.
ABSTRACT  

Radiotherapy in the Management of Thyroid Orbitopathy: Computed Tomography and Clinical Outcomes
Kao et al.
Arch Ophthalmol 1993;111:819-823.
ABSTRACT